Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A08AB01	ORLISTAT-SIGMA	G	Orlistat - 120mg	120mg	Capsule	847,965 L.L
A08AB01	ORLY SLIM	G	Orlistat - 120mg	120mg	Capsule	1,174,518 L.L
M04AA03	OXUBAT 120	G	Febuxostat - 120mg	120mg	Tablet, film coated	1,549,002 L.L
J01DD15	OMNICEF	B	Cefdinir - 125mg/5ml	125mg/5ml	Powder for suspension	1,189,301 L.L
J01DD15	OMNICEF	B	Cefdinir - 125mg/5ml	125mg/5ml	Powder for suspension	2,025,171 L.L
J01DD15	OMNICEF	B	Cefdinir - 125mg/5ml	125mg/5ml	Powder for suspension	2,025,171 L.L
J01DD15	OMNICEF	B	Cefdinir - 125mg/5ml	125mg/5ml	Powder for suspension	1,189,301 L.L
R03AC18	ONBREZ BREEZHALER	B	Indacaterol maleate - 150mcg	150mcg	Capsule, inhalation	2,284,532 L.L
L01EX09	OFEV	B	Nintedanib - 150mg	150mg	Capsule, soft	209,943,871 L.L
L01EX09	OFEV	B	Nintedanib - 150mg	150mg	Capsule, soft	L.L
J02AC01	ORAMAX	G	Fluconazole - 150mg	150mg	Capsule	170,668 L.L
A03AX13	OVOL FOR GAZ	B	Simethicone - 180mg	180mg	Capsule, liquid gel	241,892 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 1mcg	1mcg	Capsule	3,735,882 L.L
A10BJ06	OZEMPIC	B	Semaglutide - 1mg	1mg	Injectable solution	10,927,526 L.L
A10BB12	ORBIDE	G	Glimepiride - 1mg	1mg	Tablet	207,336 L.L
J06BA02	OCTAGAM	BioHuman	Human normal immunoglobulin G - 50mg/ml	2.5g/50ml	Injectable solution	19,540,934 L.L
J01MA01	OFLACIN	G	Ofloxacin - 200mg	200mg	Tablet, film-scored	602,041 L.L
J01MA01	OFLOMED	G	Ofloxacin - 200mg	200mg	Tablet, film-scored	601,530 L.L
B05BC01	OSMITOL	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	579,064 L.L
A02BC01	OMEDAR	G	Omeprazole - 20mg	20mg	Tablet, enteric coated	18,087,352 L.L
A02BC01	OMEPRAL	G	Omeprazole - 20mg	20mg	Capsule, delayed release	213,735 L.L
C10AA05	ORBALIP	G	Atorvastatin (calcium) - 20mg	20mg	Tablet	1,091,712 L.L
A02BC01	OMEPRAZOLE PHARMADEX	G	Omeprazole - 20mg	20mg	Capsule	415,951 L.L
C10AA05	ORVASTA	G	Atorvastatin - 20mg	20mg	Tablet, film coated	920,532 L.L
A02BC01	OMEPRAZOLE PHARMADEX	G	Omeprazole - 20mg	20mg	Capsule	15,757,784 L.L
A02BC01	OMEZOL BENTA	G	Omeprazole - 20mg	20mg	Capsule	550,336 L.L
A02BC01	OMEZOL BENTA	G	Omeprazole - 20mg	20mg	Capsule	317,403 L.L
A02BC01	OMEPRAL	G	Omeprazole - 20mg	20mg	Powder for suspension	712,876 L.L
N06AB03	OXETINE 20	G	Fluoxetine (HCl) - 20mg	20mg	Tablet, coated	362,837 L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 20mg	20mg	Capsule, hard	7,634,958 L.L

...